Page(s) | |
Directors’ Report | 1 – 9 |
Statement of Directors’ Responsibility | 10 |
Independent Auditors’ Report to the Board of Directors | 11-15 |
Statement of Financial Position | 16 |
Statement of Comprehensive Income | 17 |
Statement of Changes in Shareholders’ Equity | 18 |
Statement of Cash Flows | 19 |
Notes to the Financial Statements | 20 - 39 |
BM3EAC Corp. Table of Contents 31 December 2023 |
BM3EAC Corp. Directors’ Report 31 December 2023 |
BM3EAC Corp. Directors’ Report 31 December 2023 |
Event | Date |
Business Combination Deadline | 14 June 2023 |
Last trading day | 14 June 2023 |
Expiration of sponsor warrants and public warrants | 15 June 2023 |
Record date for the redemption of Units and Ordinary Shares | 16 June 2023 |
Payment of redemption proceeds | 20 June 2023 |
Redemption of Units and Ordinary Shares | 21 June 2023 |
Change of name | 9 August 2023 |
Redesignation of Units to Ordinary Shares | 9 August 2023 |
Amendment and restatement of Memorandum and Articles of Association | 9 August 2023 |
Cancellation of 25m Ordinary Shares | 12 September 2023 |
BM3EAC Corp. Directors’ Report 31 December 2023 |
Name | Position |
Vijay Rajguru | Executive Director and Chairman of the Board |
Rosalia Portela | Executive Director |
Steven P. Vincent | Non-Executive Director |
Carlos Sagasta | Independent Non-Executive Director |
Stephan Walz | Independent Non-Executive Director |
Brenda Rennick | Independent Non-Executive Director |
BM3EAC Corp. Directors’ Report 31 December 2023 |
BM3EAC Corp. Directors’ Report 31 December 2023 |
Risk category | Risk description | Potential impact |
Strategic | The Company may face significant competition for Business Combination opportunities | High |
Strategic | There is no assurance that the Company will identify suitable Business Combination opportunities | High |
BM3EAC Corp. Directors’ Report 31 December 2023 |
Strategic | The ability of the Company to negotiate a Business Combination on favorable terms could be affected by the limited time to complete the Business Combination, although the re-purposing and continuation of the Company mitigates such risk | Medium |
Financial | The Company may need to arrange third-party financing and there can be no assurance that it will be able to obtain such financing, which could compel the Company to restructure or abandon a particular proposed Business Combination | Medium |
Financial | If the Company’s working capital is insufficient, it could inhibit the Company’s search for a target business and therefore the ability to complete a Business Combination | Medium |
Operational | The Company’s success is dependent upon the Directors, Brigade and/or M3 to identify and execute a Business Combination and the departure of key individuals could adversely affect the Company group of individuals and other key personnel | Medium |
Operational | The Company’s search for a target business may be materially adversely affected by macroeconomic events as well as other adverse conditions on the public financial markets | Medium |
Operational | Harm to the reputation of the Company, the Sponsor Entity (or any of its affiliates) or the Directors may materially adversely affect the Company | Medium |
BM3EAC Corp. Directors’ Report 31 December 2023 |
BM3EAC Corp. Directors’ Report 31 December 2023 |
Name | Position |
Steven P. Vincent | Non-Executive Director |
Carlos Sagasta | Independent Non-Executive Director |
Stephan Walz | Independent Non-Executive Director |
Brenda Rennick | Independent Non-Executive Director |
Name | Position | Sponsor Shares |
Vijay Rajguru | Executive Director and chairman of the Board | 25,000 |
Rosalia Portela | Executive Director | 20,000 |
Steven P. Vincent | Non-Executive Director | - |
Carlos Sagasta | Independent Non-Executive Director | 20,000 |
Stephan Walz | Independent Non-Executive Director | 20,000 |
Brenda Rennick | Independent Non-Executive Director | 20,000 |
BM3EAC Corp. Directors’ Report 31 December 2023 |
BM3EAC Corp. Directors’ Report 31 December 2023 |
KPMG LLP |
Description of key audit matter | How the matter was addressed in our audit |
Management have identified events and conditions that may cast significant doubt on the Company’s ability to continue as a going concern. Such matters include receipt of financial support from the Sponsor Entity to fund operations. Having considered all of the relevant information, management have concluded that there are no material uncertainties that require disclosure. There is a significant risk of error relating to going concern given the judgemental nature of the matters that require consideration by management and those charged with governance. |
Report on the Audit of the Financial Statements (continued) |
Report on the Audit of the Financial Statements (continued) |
Report on the Audit of the Financial Statements (continued) |
Report on the Audit of the Financial Statements (continued) |
2023 | 2022 | ||
Note | $ | $ | |
Assets | |||
Cash | 4 | 35,590 | 369,832 |
Escrow Account | 6 | - | 258,070,782 |
Prepayments | 180 | 571,562 | |
Forward derivative agreement at fair value through profit or loss | 3 | - | 151,500 |
Total assets | 35,770 | 259,163,676 | |
Shareholders' equity and liabilities | |||
Shareholders' equity | |||
Share capital | 7 | 625 | 625 |
Retained deficit | (143,867) | (4,755,417) | |
Total shareholders' deficit | (143,242) | (4,754,792) | |
Liabilities | |||
Accrued expenses | 179,012 | 182,000 | |
Units | - | 120,287,901 | |
Redeemable Ordinary Shares | - | 137,300,617 | |
Public warrants liabilities at fair value through profit or loss | 7.3 | - | 2,350,450 |
Sponsor warrant liabilities at fair value through profit or loss | - | 3,797,500 | |
Total liabilities | 179,012 | 263,918,468 | |
Total shareholders' equity and liabilities | 35,770 | 259,163,676 |
31 December 2023 |
2023 | 2022 | ||
Note | $ | $ | |
Income | |||
Interest income | 6,315,158 | 3,074,866 | |
Net change in unrealised (losses)/gains on financial assets and liabilities at fair value through profit or loss | 7.3 | (13,079,000) | 7,932,075 |
Realised gains on financial assets and liabilities at fair value through profit or loss | 7.3 | 21,100,000 | |
Other income | 215 | - | |
Reversal of contingent settlement provision | - | 5,802,357 | |
Reversal of share based payment reserve | - | 2,215,745 | |
Total income | 14,336,373 | 19,025,043 | |
Expenses | |||
Operational expenses | 8 | 908,298 | 1,153,460 |
Interest expense calculated using the effective interest method | 8,816,525 | 23,903,339 | |
Total expenses | 9,724,823 | 25,056,799 | |
Net income/(loss) for the year | 4,611,550 | (6,031,756) | |
Total comprehensive income/(loss) for year | 4,611,550 | (6,031,756) | |
Basic earnings/(loss) per share | 10 | $0.74 | ($0.97) |
Diluted earnings/(loss) per share | 10 | $0.74 | ($0.97) |
For the year ended 31 December 2023 |
Share capital | Share based payment reserve | |||
$ | $ | $ | $ | |
Opening balance – 1 January 2022 | 625 | 2,215,745 | 1,276,339 | 3,492,709 |
Comprehensive loss for the year | - | - | (6,031,756) | (6,031,756) |
Total comprehensive loss for the year | - | - | (6,031,756) | (6,031,756) |
Capital transactions | ||||
Reversal of share based payment reserve | - | (2,215,745) | - | (2,215,745) |
Closing balance – 31 December 2022 | 625 | - | (4,755,417) | (4,754,792) |
Comprehensive income for the year | - | - | 4,611,550 | 4,611,550 |
Total comprehensive income for the year | - | - | 4,611,550 | 4,611,550 |
Closing balance – 31 December 2023 | 625 | - | (143,867) | (143,242) |
Statement of Changes in Shareholders’ Equity For the year ended 31 December 2023 |
2023 $ | 2022 $ | ||
Cash flows from operating activities: | |||
Net income/(loss) for the year | 4,611,550 | (6,031,756) | |
Adjustments to reconcile net income/(loss) for the year to net cash generated from operating activities: | |||
Adjustment for: Net change in unrealised losses/(gains) on financial assets and liabilities at fair value through profit or loss | 13,079,000 | (7,932,075) | |
Realised gains on financial assets and liabilities at fair value through profit or loss | (21,100,000) | - | |
Reversal of share based payment reserve | - | (2,215,745) | |
Reversal of contingent settlement provision | - | (5,802,357) | |
Interest expense calculated using the effective interest method | 8,816,525 | 23,903,339 | |
Changes in: | |||
Prepayments | 571,382 | 614,543 | |
Accrued expenses | (2,990) | (11,476) | |
Net cash generated from operating activities | 5,975,467 | 2,524,473 | |
Cash flows from investing activities: | |||
Deposit of interest income on Escrow Account | (6,309,709) | (3,070,781) | |
Withdrawal from Escrow Account towards redemption of Units and Redeemable Ordinary Shares | 264,380,492 | - | |
Net cash generated from/(used in) investing activities | 258,070,783 | (3,070,781) | |
Cash flows from financing activities: | |||
Redemption of Units and Redeemable Ordinary Shares | (264,380,492) | - | |
Share capital receivable | - | 625 | |
Net cash generated from/(used in) financing activities | (264,380,492) | 625 | |
Net change in cash | (334,242) | (545,683) | |
Cash at beginning of the year | 369,832 | 915,515 | |
Cash at end of the year | 35,590 | 369,832 |
Statement of Cash Flows For the year ended 31 December 2023 |
1. General information |
Notes to the Financial Statements 31 December 2023 |
1. General information (continued) |
2. Summary of material accounting policies |
2.1Basis of preparation |
2.2Use of estimates and judgements |
Notes to the Financial Statements 31 December 2023 |
2. Summary of material accounting policies (continued) |
2.3 Going concern |
2.5Functional and presentation currency |
(i)Functional currency |
(ii)Transactions and balances |
Notes to the Financial Statements 31 December 2023 |
2. Summary of material accounting policies (continued) |
2.6 Financial instruments |
(i)Recognition and initial measurement |
(ii)Classification and subsequent measurement |
Notes to the Financial Statements 31 December 2023 |
2. Summary of material accounting policies (continued) |
2.6 Financial instruments (continued) |
(iii)Amortised cost |
Notes to the Financial Statements 31 December 2023 |
2. Summary of material accounting policies (continued) |
2.6Financial instruments (continued) |
(v)Impairment |
Notes to the Financial Statements 31 December 2023 |
(vi)Derecognition |
Notes to the Financial Statements 31 December 2023 |
2. Summary of material accounting policies (continued) |
2.6 Financial instruments (continued) |
(vi)Derecognition (continued) |
2.7 Cash |
2.8Prepayments |
2.9Redeemable Ordinary Shares |
Notes to the Financial Statements 31 December 2023 |
2.10Sponsor Shares |
2.11Taxation |
2.12Related parties |
Notes to the Financial Statements 31 December 2023 |
3.Fair value measurement |
Level 1 - | Quoted prices (unadjusted) in active markets for identical assets or liabilities. |
Level 2 - | Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices). |
Level 3 - | Inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs). |
2023 | 2022 | |
Investment at the beginning of the year | $ 151,500 | $ 1,841,750 |
Net unrealized loss on forward derivatives | (151,500) | (1,690,250) |
Investment at end of the year | $ - | $ 151,500 |
Notes to the Financial Statements 31 December 2023 |
2023 | 2022 | |
Investment at the beginning of the year | $ - | $ (17,794,825) |
Net unrealized gain on warrant liabilities at fair value through profit or loss | - | 9,622,325 |
Transfer from level 3 to level 2 | - | 8,172,500 |
Investment at end of the year | $ - | $ - |
4.Cash |
2023 $ | 2022 $ | ||
Current account | 35,590 | 369,832 | |
Total cash | 35,590 | 369,832 |
5.Financial risk management |
5.1 Market risk management |
Notes to the Financial Statements 31 December 2023 |
5.2 Liquidity risk management |
3 - 12 months $ | 12 - 18 months $ | Total $ | ||
Assets | ||||
Cash | 35,590 | - | - | 35,590 |
35,590 | - | - | 35,590 | |
Liabilities | ||||
Accrued expenses | - | 179,012 | - | 179,012 |
- | 179,012 | - | 179,012 | |
Net liquidity position | 35,590 | (179,012) | - | (143,422) |
Notes to the Financial Statements 31 December 2023 |
5.Financial risk management (continued) |
5. 2 Liquidity risk management (continued) |
3 - 12 months $ | 12 - 18 months $ | Total $ | ||
Assets | ||||
Cash | 369,832 | - | - | 369,832 |
Escrow Account | - | 258,070,782 | - | 258,070,782 |
Forward derivative agreement at FVTPL | - | 151,500 | - | 151,500 |
369,832 | 258,222,282 | - | 258,592,114 | |
Liabilities | ||||
Redeemable Ordinary Shares | - | 137,300,617 | - | 137,300,617 |
Units | - | 120,287,901 | - | 120,287,901 |
Public warrant liabilities at FVTPL | - | 2,350,450 | - | 2,350,450 |
Sponsor warrant liabilities at FVTPL | - | 3,797,500 | - | 3,797,500 |
Accrued expenses | - | 182,000 | - | 182,000 |
- | 263,918,468 | - | 263,918,468 | |
Net liquidity position | 369,832 | (5,696,186) | - | (5,326,354) |
Notes to the Financial Statements 31 December 2023 |
5.Financial risk management (continued) |
5. 3 Credit risk management |
Credit Ratings | Balance as at 31 December 2023 ($) | Moody's | Standard & Poor's | Fitch |
Goldman Sachs | 35,590 | A2 | BBB+ | A |
35,590 |
Credit Ratings | Balance as at 31 December 2022 ($) | Moody's | Standard & Poor's | Fitch |
Goldman Sachs | 369,832 | A2 | BBB+ | A |
HSBC | 258,070,782 | A3 | A- | A+ |
258,440,614 |
5.4 Capital risk management |
6.Escrow Account |
Notes to the Financial Statements 31 December 2023 |
7. Capital instruments |
Notes to the Financial Statements 31 December 2023 |
2023 | 2022 | |
Financial instruments held in treasury as at | ||
Redeemable Ordinary Shares | 25,000,000 | 11,568,860 |
Public Warrants | - | 5,784,430 |
2023 | 2022 | |
Redeemable Ordinary Shares held in treasury as at | ||
Opening balance – 1 January | 11,568,860 | 25,000,000 |
Movement | 13,431,140 | (13,431,140) |
Closing balance – 31 December | 25,000,000 | 11,568,860 |
8.Operating costs |
9.Dividends |
Notes to the Financial Statements 31 December 2023 |
10.Net earnings/(loss) per share |
10.1.Basic net earnings/(loss) per share |
2023 $ | 2022 $ | |
Numerator | ||
Net earnings/(loss) for the year used in basic earnings/(loss) per share | 4,611,550 | (6,031,756) |
Total net earnings/(loss) for the year used in basic earnings/(loss) per share | 4,611,550 | (6,031,756) |
Denominator | ||
Weighted average number of Sponsor Shares used in basic earnings/ (loss) per share | 6,250,000 | 6,250,000 |
Total weighted average number of Sponsor Shares used in basic earnings/(loss) per share | 6,250,000 | 6,250,000 |
10.2.Diluted net earnings per share |
11.Related party transactions |
Notes to the Financial Statements 31 December 2023 |
11.Related party transactions (continued) |
31 December 2023 | Issued | Transfers | |||
Sponsor shares | |||||
Brigade SPAC Sponsor II LLC | 6,145,000 | - | - | - | 6,145,000 |
Vijay Rajguru (Executive director and chairman) | 25,000 | - | - | - | 25,000 |
Rosalia Portela (Executive director) | 20,000 | - | - | - | 20,000 |
Carlos Sagasta (Non-executive director) | 20,000 | - | - | - | 20,000 |
Stephan Walz (Non-executive director) | 20,000 | - | - | - | 20,000 |
Brenda Rennick (Non- executive director) | 20,000 | - | - | - | 20,000 |
6,250,000 | - | - | - | 6,250,000 |
31 December 2022 | Issued | Transfers | |||
Sponsor shares | |||||
Brigade SPAC Sponsor II LLC | 6,145,000 | - | - | - | 6,145,000 |
Vijay Rajguru (Executive director and chairman) | 25,000 | - | - | - | 25,000 |
Rosalia Portela (Executive director) | 20,000 | - | - | - | 20,000 |
Carlos Sagasta (Non-executive director) | 20,000 | - | - | - | 20,000 |
Stephan Walz (Non-executive director) | 20,000 | - | - | - | 20,000 |
Brenda Rennick (Non- executive director) | 20,000 | - | - | - | 20,000 |
6,250,000 | - | - | - | 6,250,000 |
Notes to the Financial Statements 31 December 2023 |
12.Income tax |
13.Accounting classification and fair value |
31 December 2023 | Fair Value | Fair value hierarchy level | |
Financial assets measured at amortised cost | |||
Cash | 35,590 | 35,590 | Level 1 |
35,590 | 35,590 | ||
Financial liabilities measured at amortised cost | |||
Accrued expenses | 179,012 | 179,012 | Level 2 |
179,012 | 179,012 |
Notes to the Financial Statements 31 December 2023 |
Notes to the Financial Statements 31 December 2023 |